The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(4S)-4-[[(2S)-2-[[(2S)-2-[[(2R)-2-amino-3-sulfanyl-propanoyl]amino]propanoyl]amino]-3-hydroxy-propanoyl]amino]-5-[[(1S)-2-[[(1S)-1-[[(1R)-1-carboxy-2-sulfanyl-ethyl]carbamoyl]-3-methyl-butyl]amino]-1-(hydroxymethyl)-2-oxo-ethyl]amino]-5-oxo-pentanoic acid ID: ALA5278035
Max Phase: Preclinical
Molecular Formula: C26H45N7O12S2
Molecular Weight: 711.82
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CC(C)C[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@@H](N)CS)C(=O)N[C@@H](CS)C(=O)O
Standard InChI: InChI=1S/C26H45N7O12S2/c1-11(2)6-15(23(41)33-18(10-47)26(44)45)30-25(43)17(8-35)32-22(40)14(4-5-19(36)37)29-24(42)16(7-34)31-20(38)12(3)28-21(39)13(27)9-46/h11-18,34-35,46-47H,4-10,27H2,1-3H3,(H,28,39)(H,29,42)(H,30,43)(H,31,38)(H,32,40)(H,33,41)(H,36,37)(H,44,45)/t12-,13-,14-,15-,16-,17-,18-/m0/s1
Standard InChI Key: GGXRDLLAZCVACE-GOMYCMKKSA-N
Molfile:
RDKit 2D
47 46 0 0 0 0 0 0 0 0999 V2000
-7.5120 0.4183 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-6.8009 0.8365 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.0898 0.4183 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.3787 0.8365 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-4.6676 0.4183 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.9564 0.8365 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.2453 0.4183 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.5342 0.8365 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7812 0.4183 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0701 0.8365 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.3590 0.4183 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3520 0.8365 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0632 0.4183 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.7743 0.8365 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4854 0.4183 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1966 0.8365 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.9077 0.4183 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6188 0.8365 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3717 0.4183 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.0829 0.8365 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7940 0.4183 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0829 1.6732 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7940 2.0497 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
4.6188 1.6732 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.9077 -0.4183 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6188 -0.8365 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6188 -1.6313 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3717 -0.4183 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4854 -0.4183 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.7743 1.6732 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4854 2.0497 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.3520 1.6732 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.3590 -0.4183 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3520 -0.8365 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3520 -1.6313 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0632 -2.0497 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.3590 -2.0497 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.7812 -0.4183 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-2.5342 1.6732 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7812 2.0497 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-3.9564 1.6732 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-4.6676 -0.4183 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.0898 -0.4183 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-6.8009 1.6732 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.0898 2.0497 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
7.5120 0.8251 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.7940 -0.4069 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 1 0
4 5 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 1 0
9 10 1 0
10 11 1 0
11 12 1 0
12 13 1 0
13 14 1 0
14 15 1 0
15 16 1 0
16 17 1 0
17 18 1 0
18 19 1 0
19 20 1 0
20 21 1 0
20 22 1 1
22 23 1 0
18 24 2 0
17 25 1 6
25 26 1 0
26 27 1 0
26 28 1 0
15 29 2 0
14 30 1 1
30 31 1 0
12 32 2 0
11 33 1 6
33 34 1 0
34 35 1 0
35 36 2 0
35 37 1 0
9 38 2 0
8 39 1 1
39 40 1 0
6 41 2 0
5 42 1 6
3 43 2 0
2 44 1 1
44 45 1 0
21 46 1 0
21 47 2 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 711.82Molecular Weight (Monoisotopic): 711.2568AlogP: -4.92#Rotatable Bonds: 22Polar Surface Area: 315.68Molecular Species: ACIDHBA: 13HBD: 13#RO5 Violations: 3HBA (Lipinski): 19HBD (Lipinski): 12#RO5 Violations (Lipinski): 3CX Acidic pKa: 3.55CX Basic pKa: 7.78CX LogP: -7.55CX LogD: -10.53Aromatic Rings: ┄Heavy Atoms: 47QED Weighted: 0.05Np Likeness Score: 0.31
References 1. Cuffaro D, Ciccone L, Rossello A, Nuti E, Santamaria S.. (2022) Targeting Aggrecanases for Osteoarthritis Therapy: From Zinc Chelation to Exosite Inhibition., 65 (20.0): [PMID:36250680 ] [10.1021/acs.jmedchem.2c01177 ]